임상 리스크 분류 솔루션 : 시장 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The Clinical Risk Grouping Solutions Market size is estimated at USD 0.72 billion in 2024, and is expected to reach USD 1.41 billion by 2029, growing at a CAGR of 14.48% during the forecast period (2024-2029).

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care. Besides, accuracy in risk assessment and growing investments in R&D of new therapeutics is anticipated to boost the market growth over the forecast period. Furthermore, the compilation of patient information in a healthcare setting, resulting in physician burden, increases the demand for clinical risk grouping solutions.

However, lack of skilled professionals, concerns regarding the private cloud data management, and high costs related to management solutions are projected to hamper the market growth over the forecast period.

Clinical Risk Grouping Solutions Market Trends

Dashboard and Data Visualisation Tools are Anticipated to Grow at Significant Rate

Dashboard and data visualization tools are anticipated to grow at notable rates owing to its ability to predict the payment process and predict payment risk. Besides, increasing the need to reduce healthcare costs coupled with the increasing adoption of big data is anticipated to boost the market growth over the forecast period. Moreover, the adoption of cloud-based technologies to manage clinical data and the growing prevalence of chronic diseases is expected to fuel market growth.

The hospital segment is anticipated to have notable market growth owing to increasing adoption of big data, growing focus of caregivers in risk management solution, increasing investment in infrastructure to enhance the healthcare facilities to improve the care.

North America Expected to Have Significant Market Growth

Among the regional segment, North America is expected to have significant market growth over the forecast period. This growth is attributed to the growing prevalence of chronic diseases, well-established healthcare infrastructure, and the high adoption of advanced technologies and government initiatives to mandate health records maintenance.

However, the Asia Pacific region is projected to have lucrative market growth opportunities due to the presence of a large pool of patient populations, increasing need for better risk management solutions, adoption of recording and maintaining the health records, and growing prevalence of chronic diseases.

Clinical Risk Grouping Solutions Industry Overview

The global clinical risk grouping market is moderately consolidated and competitive. Market players are focusing on new product launches, product innovations, and geographical expansion. F. The key market players operating in the market include 3M Company, Optum Inc., Conduent Inc., Lightbeam Health Solutions, and Health Catalyst.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Demand for Clinical Risk Management and Adoption of Big Data in Healthcare
  • 4.2.2 Advancements in Data Management to Improve the Clinical Operations
• 4.3 Market Restraints
  • 4.3.1 Concerns Regarding the Private Cloud Data Breaches
  • 4.3.2 High Cost Related to Clinical Solutions
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Deployment
  • 5.1.1 Public Cloud
  • 5.1.2 Private Cloud
  • 5.1.3 Hybrid Cloud
• 5.2 By Product
  • 5.2.1 Dashboard Analytics
  • 5.2.2 Scorecard and Data Visualization Tools
  • 5.2.3 Risk Reporting Solutions
• 5.3 By End User
  • 5.3.1 Pharmaceuticals
  • 5.3.2 Clinical Research organizations
  • 5.3.3 Other End User
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 3M Company
  • 6.1.2 Optum Inc.
  • 6.1.3 Conduent Inc.
  • 6.1.4 Lightbeam Health Solutions
  • 6.1.5 Health Catalyst
  • 6.1.6 HBI Solutions
  • 6.1.7 Dynamic Healthcare Systems Inc.
  • 6.1.8 4S Information Systems Ltd
  • 6.1.9 Evolent Health Inc.
  • 6.1.10 PeraHealth Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS